drugset / Trial / NCT00515736

Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome

NCT00515736

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Critically ill patients are generally exposed to an increased oxidative stress, which is proportional to the severity of their condition. Endogenous antioxidant (AOX) defenses are depleted particularly in those patients with intense inflammatory response. The hypothesis tested is that early I:V: administration of a combination of AOX micronutrient supplements (Se, Zn, Vit C, Vit E, Vit B1) would improve clinical outcome in selected critically ill patients, by reinforcing the endogenous AOX defenses and reducing organ failure.

Timeline

Start
2003-01
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Selenium Other / unclassified 270 ug Intravenous
Subject Thiamine Other / unclassified 100 mg Intravenous
Subject Vitamin C Other / unclassified 1.1 g Intravenous
Subject Vitamin E Other / unclassified 300 mg Intravenous
Subject Zinc - Laboratoire Aguettant, the others generic Other / unclassified 30 mg Intravenous